Inaugural operating profit fails to lift 111 Inc.
The drug distributor expects to benefit from an ongoing crackdown on corruption in its industry due to the company’s focus on distribution to pharmacies rather than hospitals Key Takeaways: 111…
FAST NEWS: 111 Inc’s Revenue Flattens on Covid Disruptions
The Latest: Online drug seller 111 Inc. (YI.US) on Thursday reported third-quarter revenue of 3.35 billion yuan ($470.8 million), roughly the same as a year earlier. Its net loss for…
Online Drug Supplier 111 Finds Tonic in B2B Focus
Company adds two fulfillment centers, inks deal with cancer drug maker BeiGene, in drive to consolidate its place as premier B2B specialist Key takeaways 111 Inc.’s aggressive pursuit of partnerships…